Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A prospective whole Scottish population study of genetic and immune causes of epilepsy and complex febrile seizures in children under three years of age: the Genetic and Autoimmune Childhood Epilepsy (GACE) Study

Symonds J. et al, (2018), SCOTTISH MEDICAL JOURNAL, 63, 35 - 36

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability

Dawes JM. et al, (2018), Neuron, 97, 806 - 822.e10

A passive transfer animal model of CASPR2 antibodies

Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674

Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology

Balint B. et al, (2018), Brain, 141, 13 - 36

Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes

Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient

Saxena A. et al, (2017), Scientific Reports, 7

High sensitivity and specificity in proposed clinical diagnostic criteria for anti-N -methyl-D -aspartate receptor encephalitis

Ho ACC. et al, (2017), Developmental Medicine & Child Neurology, 59, 1256 - 1260

Cell- and Single Molecule-Based Methods to Detect Anti- N -Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project

Jézéquel J. et al, (2017), Biological Psychiatry, 82, 766 - 772

Paraneoplastic cerebellar degeneration and lambert‐eaton myasthenia in a patient with merkel cell carcinoma and voltage‐gated calcium channel antibodies

Pavolucci L. et al, (2017), Muscle & Nerve, 56, 998 - 1000

Disease course and disability outcomes in MOG-antibody disease in the UK

Jurynczyk M. et al, (2017), MULTIPLE SCLEROSIS JOURNAL, 23, 82 - 82

Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero

Coutinho E. et al, (2017), Acta Neuropathologica, 134, 567 - 583

SHP2: A Potential Therapeutic Agent for MuSK-Myasthenia

Cao M. et al, (2017), ANNALS OF NEUROLOGY, 82, S34 - S34

CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism

Coutinho E. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 718 - 721

Pathogenic potential of antibodies to the GABAB receptor

Nibber A. et al, (2017), Epilepsia Open, 2, 355 - 359

Diagnostic algorithm for relapsing acquired demyelinating syndromes in children

Hacohen Y. et al, (2017), Neurology, 89, 269 - 278

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

Huda S. et al, (2017), Neurology - Neuroimmunology Neuroinflammation, 4, e357 - e357

Screening for antibodies in narcolepsy type 1 and type 2

Giannoccaro MP. et al, (2017), EUROPEAN JOURNAL OF NEUROLOGY, 24, 79 - 79

Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors

Crisp SJ. et al, (2017), Current Opinion in Neurology, 30, 310 - 316

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis

Miller TD. et al, (2017), Brain, 140, 1212 - 1219

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Lang B. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 353 - 361

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?